AIFM2 and cancer: Various experimental cancer models have shown that ferroptosis inducers, that target ferroptosis-suppressor-protein 1 (FSP1) and glutathione peroxidase 4 (GPX4), deplete glutathione (GSH), or enhance the iron pool, can effectively kill cancer cells, especially drug-resistant cancer cells (50).